Drug
Efmarodocokin alfa clinical trials
Also written UTTR1147A and RO7021610.
- studies test it
- 6
- open now
- 0
- in phase 3
- 0
- first study started
- 2016
How studies write it
Studies that test it under each name
Studies by the year they started
6 studies that test it; most in 2016 (2)
| Year | Studies |
|---|---|
| 2016 | 2 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 2 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 3
- Phase 2
- 3
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 6 · Other 0
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses efmarodocokin alfa is read from its arms, and is right about nine times in ten.
Testing it · 6
- Study to Evaluate the Safety and Pharmacokinetics of Efmarodocokin Alfa in Combination With Standard of Care in Participants Undergoing Allogeneic Hematopoietic Stem Cell TransplantationCompletedPhase 1Genentech, Inc.NCT04539470Written as Efmarodocokin Alfa
- An Extension Study to Evaluate the Long-Term Safety and Tolerability of UTTR1147A in Participants With Moderate to Severe Ulcerative Colitis or Crohn's DiseaseTerminatedPhase 2Genentech, Inc.NCT03650413Written as UTTR1147A
- A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of UTTR1147A Compared With Placebo and With Vedolizumab in Participants With Moderate to Severe Ulcerative Colitis (UC)CompletedPhase 2Genentech, Inc.NCT03558152Written as UTTR1147A
- A Study to Evaluate the Safety and Efficacy of MSTT1041A (Astegolimab) or UTTR1147A in Patients With Severe COVID-19 PneumoniaCompletedPhase 2Genentech, Inc.NCT04386616Written as UTTR1147A
- A Safety Study of Intravenously Administered UTTR1147A in Healthy Volunteers (HVs), Participants With Ulcerative Colitis (UC), and Participants With Crohn's Disease (CD)CompletedPhase 1Genentech, Inc.NCT02749630Written as UTTR1147A
- The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of UTTR1147A in Participants With Neuropathic Non-Healing Diabetic Foot UlcersCompletedPhase 1Genentech, Inc.NCT02833389Written as UTTR1147A
Codes
What other systems call efmarodocokin alfa · ClinicalTrials.gg INT017428
- UNII (FDA) NYZ11835VXEFMARODOCOKIN ALFAOne source FDA
- NCI Thesaurus C174771Efmarodocokin AlfaOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | NYZ11835VX | EFMARODOCOKIN ALFA | One source FDA |
| NCI Thesaurus | C174771 | Efmarodocokin Alfa | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.